Double-stranded sperm DNA fragmentation measured with neutral comet assay as a predictor of IVF outcomes: evidence from three European clinics in a multi-centred prospective study - PubMed
7 hours ago
- #neutral comet assay
- #IVF outcomes
- #sperm DNA fragmentation
- Double-stranded sperm DNA fragmentation (dsSDF) measured by neutral comet assay is a strong, independent predictor of live birth following IVF.
- Higher dsSDF levels correlate with reduced odds of live birth, with each 1-point increase in Average Comet Score (ACS) linked to 16% lower odds and each 1-point increase in Incidence of Damage (IOD) to 5% lower odds.
- A pragmatic threshold of IOD ≥ 6% identifies couples with approximately half the odds of achieving a live birth compared to those with lower IOD at similar female ages.
- The adverse impact of dsSDF on live birth is stronger at higher female ages, though female age itself remains a significant inverse predictor.
- The study involved 302 males from three European IVF clinics over three years, with 126 healthy sperm donors as controls, and used multivariable logistic regression adjusting for age and center.
- Limitations include focus on first IVF cycles only, potential center-level confounding, and lack of adjustment for cycle-level covariates like IVF/ICSI method or embryo transfer strategy.
- Results support dsSDF as a clinically relevant biomarker that complements conventional semen parameters for predicting IVF outcomes.